Home
>
National Drug Code (NDC)
>
Mysoline
Mysoline - 66490-691-10 - (Primidone)
Drug Information of Mysoline
| Product NDC: | 66490-691 |
| Proprietary Name: | Mysoline |
| Non Proprietary Name: | Primidone |
| Active Ingredient(s): | 250 mg/1 & nbsp; Primidone |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Mysoline
| Product NDC: | 66490-691 |
| Labeler Name: | Valeant Pharmaceuticals North America |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA009170 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20090624 |
Package Information of Mysoline
| Package NDC: | 66490-691-10 |
| Package Description: | 100 TABLET in 1 BOTTLE (66490-691-10) |
NDC Information of Mysoline
| NDC Code | 66490-691-10 |
| Proprietary Name | Mysoline |
| Package Description | 100 TABLET in 1 BOTTLE (66490-691-10) |
| Product NDC | 66490-691 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Primidone |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20090624 |
| Marketing Category Name | NDA |
| Labeler Name | Valeant Pharmaceuticals North America |
| Substance Name | PRIMIDONE |
| Strength Number | 250 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE] |
